KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Tenet Healthcare (THC) over the last 15 years, with Q4 2025 value amounting to $90.1 million.

  • Tenet Healthcare's Shares Outstanding (Weighted Average) fell 696.98% to $90.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $90.1 million, marking a year-over-year decrease of 696.98%. This contributed to the annual value of $90.1 million for FY2025, which is 696.98% down from last year.
  • Per Tenet Healthcare's latest filing, its Shares Outstanding (Weighted Average) stood at $90.1 million for Q4 2025, which was down 696.98% from $91.1 million recorded in Q3 2025.
  • Tenet Healthcare's Shares Outstanding (Weighted Average)'s 5-year high stood at $107.9 million during Q3 2022, with a 5-year trough of $90.1 million in Q4 2025.
  • Over the past 5 years, Tenet Healthcare's median Shares Outstanding (Weighted Average) value was $101.9 million (recorded in 2023), while the average stood at $101.3 million.
  • In the last 5 years, Tenet Healthcare's Shares Outstanding (Weighted Average) skyrocketed by 193.52% in 2021 and then plummeted by 696.98% in 2025.
  • Quarter analysis of 5 years shows Tenet Healthcare's Shares Outstanding (Weighted Average) stood at $106.8 million in 2021, then rose by 0.09% to $106.9 million in 2022, then dropped by 4.95% to $101.6 million in 2023, then dropped by 4.66% to $96.9 million in 2024, then dropped by 6.97% to $90.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $90.1 million for Q4 2025, versus $91.1 million for Q3 2025 and $92.7 million for Q2 2025.